Study to Evaluate MEDI-534 in Healthy Adults
NCT00111878
·
clinicaltrials.gov ↗
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Respiratory Syncytial Virus Infections
Parainfluenza Infections
Interventions
DRUG:
MEDI-534
Sponsor
MedImmune LLC